Launch Pricing

Insights on new policy development regarding launch pricing for innovative drugs in China.
Apr 17, 2024

Quantifying Innovation: Three Key Signals from NHSA's Draft on New Chemical Drug Launch Pricing

The standout enhancement in the current proposal is the addition of a self-assessment scale. This tool, designed to assign a score that quantifies innovation quality based on the company's self-assessment, plays a crucial role in determining the initial pricing of their drugs.
Dec 06, 2023

NHSA Proposes Launch Price Framework and Aligns Pricing Policies with Drug Lifecycle

At a recent industry investor conference, Weng Linjia, Deputy Director of the Pharmaceutical Pricing and Tender Procurement Department, National Healthcare